| abstract |
The present invention relates to the use of certain β-adrenergic agonists,ntheir pharmaceutically acceptable prodrugs, pharmaceutically acceptable saltsnof either entity, or pharmaceutical compositions containing any of the foregoing,nfor the manufacture of a medicament to reduce a wasting condition in anmammal (e.g., human). |